These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29604936)

  • 1. Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis.
    Cho AA; Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):49-61. PubMed ID: 29604936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
    Bonavida B; Baritaki S
    Crit Rev Oncog; 2011; 16(3-4):211-26. PubMed ID: 22248055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic YY1 Inhibitors in Cancer: ALL in ONE.
    Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):37-47. PubMed ID: 29604935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Forgotten YY2 in Reported YY1 Expression Levels in Human Cancers.
    Kaufhold S; Aziz N; Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):63-73. PubMed ID: 29604937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.
    Bonavida B; Baritaki S
    Nitric Oxide; 2011 Jan; 24(1):1-7. PubMed ID: 20933602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YY1 Is an Inducer of Cancer Metastasis.
    Wang W; Li D; Sui G
    Crit Rev Oncog; 2017; 22(1-2):1-11. PubMed ID: 29604932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.
    Huerta-Yepez S; Baritaki S; Baay-Guzman G; Hernandez-Luna MA; Hernandez-Cueto A; Vega MI; Bonavida B
    Nitric Oxide; 2013 Feb; 29():17-24. PubMed ID: 23246440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: a therapeutic target.
    Bonavida B; Kaufhold S
    Pharmacol Ther; 2015 Jun; 150():149-68. PubMed ID: 25619146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
    Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Yin and Yang of YY1 in tumor growth and suppression.
    Khachigian LM
    Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells.
    Gao D; Wang L; Zhang H; Yan X; Yang J; Zhou R; Chang X; Sun Y; Tian S; Yao Z; Zhang K; Liu Z; Ma Z
    FEBS J; 2018 Nov; 285(22):4229-4245. PubMed ID: 30251328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
    Kaufhold S; Garbán H; Bonavida B
    J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of YY1 in oncogenesis and its potential as a drug target in cancer therapies.
    Shi J; Hao A; Zhang Q; Sui G
    Curr Cancer Drug Targets; 2015; 15(2):145-57. PubMed ID: 25817371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer.
    Wottrich S; Kaufhold S; Chrysos E; Zoras O; Baritaki S; Bonavida B
    Drug Resist Updat; 2017 Jan; 30():28-38. PubMed ID: 28363333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Epithelial-to-Mesenchymal Transition (EMT) in Cancer by Nitric Oxide: Pivotal Roles of Nitrosylation of NF-κB, YY1 and Snail.
    Bonavida B; Baritaki S
    For Immunopathol Dis Therap; 2012; 3(2):125-133. PubMed ID: 24729932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.
    Yang T; Shu F; Yang H; Heng C; Zhou Y; Chen Y; Qian X; Du L; Zhu X; Lu Q; Yin X
    Metabolism; 2019 Jul; 96():33-45. PubMed ID: 31028762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer.
    Liu J; Chen X; Ward T; Mao Y; Bockhorn J; Liu X; Wang G; Pegram M; Shen K
    Int J Biochem Cell Biol; 2016 Feb; 71():12-23. PubMed ID: 26643609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Multilayered Regulation of the Oncogenic Protein YY1.
    Rizkallah R; Hurt MM
    Crit Rev Oncog; 2017; 22(1-2):109-129. PubMed ID: 29604940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop.
    Bonavida B
    Crit Rev Oncog; 2014; 19(6):431-45. PubMed ID: 25597353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.